ATE71620T1 - N-substituierte 3,4-dihydropyrimidinverbindungen als mittel zur behandlung von erkrankungen des kardiovaskularen systems. - Google Patents

N-substituierte 3,4-dihydropyrimidinverbindungen als mittel zur behandlung von erkrankungen des kardiovaskularen systems.

Info

Publication number: ATE71620T1
Authority: AT; Austria
Prior art keywords: agents; substituted; cardiovascular system; carbon atoms; diseases
Prior art date: 1987-02-21

Application number

AT88102557T

Other languages

English (en)

Inventor

Hidetsura Cho

Masaru Ueda

Original Assignee

Suntory Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-02-21

Filing date

1988-02-22

Publication date

1992-02-15

1988-02-22 Application filed by Suntory Ltd filed Critical Suntory Ltd

1992-02-15 Application granted granted Critical

1992-02-15 Publication of ATE71620T1 publication Critical patent/ATE71620T1/de

Links

-1 N-SUBSTITUTED 3,4-DIHYDROPYRIMIDINE COMPOUNDS Chemical class 0.000 title abstract 3
210000000748 cardiovascular system Anatomy 0.000 title abstract 2
201000010099 disease Diseases 0.000 title 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
125000004432 carbon atom Chemical group C* 0.000 abstract 3
125000000217 alkyl group Chemical group 0.000 abstract 2
229910052739 hydrogen Inorganic materials 0.000 abstract 2
239000001257 hydrogen Substances 0.000 abstract 2
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
125000003545 alkoxy group Chemical group 0.000 abstract 1
239000004004 anti-anginal agent Substances 0.000 abstract 1
229940124345 antianginal agent Drugs 0.000 abstract 1
239000002220 antihypertensive agent Substances 0.000 abstract 1
229940030600 antihypertensive agent Drugs 0.000 abstract 1
239000003795 chemical substances by application Substances 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
125000004122 cyclic group Chemical group 0.000 abstract 1
229910052736 halogen Inorganic materials 0.000 abstract 1
150000002367 halogens Chemical class 0.000 abstract 1
150000002431 hydrogen Chemical class 0.000 abstract 1
125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
230000002045 lasting effect Effects 0.000 abstract 1
125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
230000000304 vasodilatating effect Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/20—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Cardiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Heart & Thoracic Surgery (AREA)
General Health & Medical Sciences (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AT88102557T 1987-02-21 1988-02-22 N-substituierte 3,4-dihydropyrimidinverbindungen als mittel zur behandlung von erkrankungen des kardiovaskularen systems. ATE71620T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP62038345A JPS63208580A (ja)	1987-02-21	1987-02-21	Ｎ置換３，４−ジヒドロピリミジン誘導体および循環器系疾患治療剤
EP88102557A EP0280227B1 (de)	1987-02-21	1988-02-22	N-Substituierte 3,4-Dihydropyrimidinverbindungen als Mittel zur Behandlung von Erkrankungen des kardiovaskularen Systems

Publications (1)

Publication Number	Publication Date
ATE71620T1 true ATE71620T1 (de)	1992-02-15

Family

ID=12522695

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT88102557T ATE71620T1 (de)	1987-02-21	1988-02-22	N-substituierte 3,4-dihydropyrimidinverbindungen als mittel zur behandlung von erkrankungen des kardiovaskularen systems.

Country Status (6)

Country	Link
US (1)	US4920124A (de)
EP (1)	EP0280227B1 (de)
JP (1)	JPS63208580A (de)
AT (1)	ATE71620T1 (de)
DE (1)	DE3867652D1 (de)
ES (1)	ES2039485T3 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6268369B1 (en)	1994-11-16	2001-07-31	Synaptic Pharmaceutical Corporation	5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines
EE9700209A (et)	1994-11-16	1998-04-15	Synaptic Pharmaceutical Corporation	Dihüdropürimidiinid ja nende kasutamine
US6228861B1 (en)	1995-11-16	2001-05-08	Synaptic Pharmaceutical Corporation	Dihydropyrimidines and uses thereof
US6245773B1 (en)	1996-05-16	2001-06-12	Synaptic Pharmaceutical Corporation	5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines
US6172066B1 (en)	1996-05-16	2001-01-09	Synaptic Pharmaceutical Corporation	Dihydropyrimidines and uses thereof
US6680323B2 (en)	1998-12-23	2004-01-20	Synaptic Pharmaceutical Corporation	Dihydropyrimidines and uses thereof
US6274585B1 (en)	1998-12-23	2001-08-14	Synaptic Pharmaceutical Corporation	Dihydropyrimidines and uses thereof
US6720324B2 (en)	2000-07-05	2004-04-13	Synaptic Pharmaceutical Corporation	Selective melanin concentrating hormone-1 (MCH1) receptor antagonists and uses thereof
WO2005007124A2 (en)	2003-07-23	2005-01-27	Bristol-Myers Squibb Company	Substituted dihydropyrimidine inhibitors of calcium channel function

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3234684A1 (de) *	1982-09-18	1984-03-22	Bayer Ag, 5090 Leverkusen	Neue dihydropyrimidine, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
JPS60214778A (ja) *	1984-03-08	1985-10-28	Suntory Ltd	Ν置換３，４−ジヒドロピリミジン誘導体ならびにその製造法および用途
US4683234A (en) *	1984-05-19	1987-07-28	Suntory Limited	2,6-Dimethyl-3N,5-disubstituted-4-(substituted phenyl)3,4-dihydropyrimidine compounds and a method for treating disorders of cardiocircular system
ATE78816T1 (de) *	1985-03-15	1992-08-15	Suntory Ltd	N-substituierte 3,4-dihydropyrimidinderivate, verfahren zu deren herstellung und diese enthaltende zusammenstellung fuer die behandlung von anordnungen eines kardiovascularen systems.

1987
- 1987-02-21 JP JP62038345A patent/JPS63208580A/ja active Pending
1988
- 1988-02-19 US US07/157,777 patent/US4920124A/en not_active Expired - Fee Related
- 1988-02-22 EP EP88102557A patent/EP0280227B1/de not_active Expired - Lifetime
- 1988-02-22 ES ES198888102557T patent/ES2039485T3/es not_active Expired - Lifetime
- 1988-02-22 DE DE8888102557T patent/DE3867652D1/de not_active Expired - Lifetime
- 1988-02-22 AT AT88102557T patent/ATE71620T1/de not_active IP Right Cessation

Also Published As

Publication number	Publication date
EP0280227B1 (de)	1992-01-15
ES2039485T3 (es)	1993-10-01
US4920124A (en)	1990-04-24
JPS63208580A (ja)	1988-08-30
EP0280227A1 (de)	1988-08-31
DE3867652D1 (de)	1992-02-27

Similar Documents

Publication	Publication Date	Title
ATE165097T1 (de)	1998-05-15	Anwendung von indolocarbazol-derivaten zur behandlung von prostataerkrankungen
DE69411424D1 (de)	1998-08-13	Zur Behandlung von Erkrankungen des Zentralnervensystems verwendbare Benzimidazole
ATE192045T1 (de)	2000-05-15	Verwendung von substituierten adeninderivaten zur behandlung von multiplesklerose
ATE86247T1 (de)	1993-03-15	3-indolpyruvsaeure-derivate und deren verwendung als arznemittel.
FI935529A0 (fi)	1993-12-09	Aminometylensubstituerade icke-aromatiska heterocykliska foereningar
DE68914292D1 (de)	1994-05-11	Zusammensetzung zur Behandlung von ischämischen Störungen in Organen.
ES2038609T3 (es)	1993-08-01	4,5-dihidroisoxazol, 3,5 disustituido como inhibidores de transglutaminasa.
ATE112762T1 (de)	1994-10-15	Herstellung und verwendung von n-jodopropargyl- oxycarbonylaminosäure-estern als antimicrobielle mittel.
DE69331171D1 (de)	2002-01-03	Chinolin und Chinazolin Derivate zur Behandlung von Arthritis
ATE71620T1 (de)	1992-02-15	N-substituierte 3,4-dihydropyrimidinverbindungen als mittel zur behandlung von erkrankungen des kardiovaskularen systems.
ATE319680T1 (de)	2006-03-15	Substituierte 2-benzylamino-2-phenyl- acetamidverbindungen
ATE180669T1 (de)	1999-06-15	Verwendung von pregnanderivaten zur behandlung von tumoren
ES2038668T3 (es)	1993-08-01	Vasodilatadores de benzotiazepina dotados de sustitucion aralquilica.
ATE148109T1 (de)	1997-02-15	Hiv-proteaseinhibitoren und ihre verwendung zur behandlung von aids
ATE135211T1 (de)	1996-03-15	5-aryl-4-alkyl-3h-1,2,4-triazol-3-thione zur verbesserung des gedächtnisses
ATE150751T1 (de)	1997-04-15	Neuroprotektive 3,4-dihydro-2(1h)-chinolone
NO152370C (no)	1985-09-18	Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,8-dihydroksy-9-(1oh) antracenon-derivater
DE3779813D1 (en)	1992-07-23	1,4-dihydropyridinderivate.
DK601583D0 (da)	1983-12-27	Carbamyloxybenzhydrolderivater
DE69827706D1 (de)	2004-12-30	5-(Heteroaryl)alkyl)-3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid (PBI) Derivate zur Behandlung von Störungen des zentralen Nervensystems
DE69823650D1 (de)	2004-06-09	Azasteroidverbindung zur behandlung oder vorbeugung von prostatakrebs
ATE132038T1 (de)	1996-01-15	Verbindung zur behandlung von störungen des neurotransmittersystems im gehirn
ATE264840T1 (de)	2004-05-15	Azetidincarboxamid-derivate zur behandlung von zns störungen
DE69619088D1 (de)	2002-03-21	Quinoxalin-Derivate zur Behandlung von Tinnitus
ATE64095T1 (de)	1991-06-15	Verwendung von imidazochinazolinen zur behandlung und verhinderung von nephritis.

Legal Events

Date	Code	Title	Description
1992-09-15	UEP	Publication of translation of european patent specification
1998-11-15	REN	Ceased due to non-payment of the annual fee